Express Scripts Given New $64.00 Price Target at Citigroup (ESRX)

Express Scripts (NASDAQ: ESRX) had its price target lifted by Citigroup to $64.00 in a research note released on Thursday morning. They currently have a buy rating on the stock.

Express Scripts traded down 0.16% on Thursday, hitting $57.27. Express Scripts has a 1-year low of $49.79 and a 1-year high of $66.06. The stock’s 50-day moving average is currently $55.04. The company has a market cap of $46.875 billion and a price-to-earnings ratio of 32.72.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet reiterated a buy rating on shares of Express Scripts in a research note to investors on Thursday. Separately, analysts at Oppenheimer reiterated an outperform rating on shares of Express Scripts in a research note to investors on Wednesday, February 20th. They now have a $62.00 price target on the stock, up previously from $60.00. Finally, analysts at Lazard Capital Markets raised their EPS on shares of Express Scripts in a research note to investors on Wednesday, February 20th. They now have a buy rating and a $65.00 price target on the stock.

Eighteen equities research analysts have rated the stock with a buy rating, two have issued an overweight rating, and five have issued a hold rating to the company’s stock. The company presently has an average rating of buy and an average target price of $63.55.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows
Woman once on Death Row to Go Free
Woman once on Death Row to Go Free
Bidding for Back Bay Parking Spaces Reaches $560,000
Bidding for Back Bay Parking Spaces Reaches $560,000
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe